Medical Oncology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,100,544 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 929,139 |
| Insertion of needle into vein for collection of blood sample | 830,297 |
| Established patient office or other outpatient visit, 40-54 minutes | 466,774 |
| Established patient office or other outpatient visit, 20-29 minutes | 402,957 |
| Injection of drug or substance under skin or into muscle | 313,294 |
| Administration of chemotherapy into vein, 1 hour or less | 286,926 |
| Injection of additional new drug or substance into vein | 273,879 |
| Blood test, comprehensive group of blood chemicals | 269,529 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 197,225 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 142,444 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 118,858 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 114,546 |
| New patient office or other outpatient visit, 60-74 minutes | 88,925 |
| Administration of chemotherapy into vein, each additional hour | 83,099 |
| Administration of additional new drug or substance into vein, 1 hour or less | 76,706 |
| Lactate dehydrogenase (enzyme) level | 66,049 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 58,662 |
| Ferritin (blood protein) level | 57,582 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 56,478 |
| New patient office or other outpatient visit, 45-59 minutes | 53,512 |
| Iron level | 51,328 |
| Infusion into a vein for hydration, each additional hour | 51,208 |
| Iron binding capacity | 49,123 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 46,104 |
| Gammaglobulin (immune system protein) measurement | 44,564 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40,073 |
| Flow cytometry technique for dna or cell analysis, each additional marker | 37,926 |
| Magnesium level | 34,340 |
| Infusion into a vein for hydration, 31-60 minutes | 30,029 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 26,487 |
| Unclassified drugs | 24,573 |
| Blood test, thyroid stimulating hormone (tsh) | 22,780 |
| Injection of drug or substance into vein | 22,721 |
| Administration of additional new drug or substance into vein using push technique | 21,717 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 21,671 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 21,014 |
| Cyanocobalamin (vitamin b-12) level | 19,762 |
| Irrigation of implanted venous access drug delivery device | 18,304 |
| Carcinoembryonic antigen (cea) protein level | 18,015 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 17,934 |
| Measurement of immunoglobulin light chains | 17,472 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 16,670 |
| Microscopic examination for white blood cells with manual cell count | 16,501 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 15,781 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 14,760 |
| Folic acid level, serum | 14,275 |
| Red blood count, automated test | 14,005 |
| Established patient office or other outpatient visit, 10-19 minutes | 12,469 |
| Automated urinalysis test | 12,417 |
| Blood test, basic group of blood chemicals (calcium, total) | 12,088 |
| Red blood count automated, with additional calculations | 11,720 |
| Ct scan of chest with contrast | 11,461 |
| Psa (prostate specific antigen) measurement, total | 11,392 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 11,372 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 10,952 |
| Phosphate level | 10,866 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 10,784 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 10,362 |
| Uric acid level, blood | 10,268 |
| Blood test, clotting time | 9,924 |
| New patient office or other outpatient visit, 30-44 minutes | 9,686 |
| Ct scan of abdomen and pelvis with contrast | 9,686 |
| Thyroxine (thyroid chemical), free | 9,461 |
| Drawing of blood for a medical problem | 8,664 |
| Reticulated (young) platelet measurement | 7,803 |
| Protein measurement, serum | 7,510 |
| Collection of blood sample from implanted device | 7,410 |
| Telephone medical discussion with physician, 21-30 minutes | 7,283 |
| Liver function blood test panel | 7,058 |
| Telephone medical discussion with physician, 11-20 minutes | 6,468 |
| Nephelometry, test method using light | 5,796 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 5,627 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 4,992 |
| Hospital discharge day management, more than 30 minutes | 4,861 |
| Immunologic analysis technique on serum (immunofixation) | 4,840 |
| Vitamin d-3 level | 4,071 |
| Measurement of substance using immunoassay technique | 3,906 |
| Beta-2 microglobulin (protein) level | 3,828 |
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 3,651 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 3,426 |
| Bilirubin level, total | 3,358 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 3,345 |
| Phosphatase (enzyme) level, alkaline | 3,240 |
| Liver enzyme (sgot), level | 3,238 |
| Ct scan of chest without contrast | 3,200 |
| Blood creatinine level | 3,159 |
| Total protein level, blood | 3,098 |
| Liver enzyme (sgpt), level | 3,067 |
| Telephone medical discussion with physician, 5-10 minutes | 3,022 |
| Hospital discharge day management, 30 minutes or less | 2,986 |
| Albumin (protein) level | 2,983 |
| Application of on-body injector for under skin injection | 2,887 |
| Calcium level, total | 2,667 |
| Administration of chemotherapy into vein using push technique | 2,581 |
| Blood potassium level | 2,494 |
| Blood chloride level | 2,473 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 2,471 |
| Blood sodium level | 2,410 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 2,309 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).